ABT
Abbott Laboratories
B-
64.7 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
9.4%
-
Operating Margin Trend
-0.93 pp/yr
-
5yr Avg ROE
15.2%
-
5yr Share-Count CAGR
-0.6%
-
5yr Revenue CAGR
0.7%
-
5yr EPS CAGR
-1.4%
-
Revenue-Growth Years (5)
4/5
-
5yr FCF Margin
16.5%
-
5yr FCF/NI Conversion
0.97x
-
Net Debt / EBITDA
0.53x
-
Interest Coverage (EBIT/Int)
25.83x
-
Altman Z-Score
2.96
Stability
Weight: 15%
C-
47
-
EPS Volatility (σ/μ)
0.67
-
Piotroski F-Score
6
-
Negative-Revenue Years (5)
1/5
5 of 5 gurus held; 1 new buy; 2 added; 2 trimmed; 1 full exit.
- Holders
- 5
+1
- Avg Δ position
-
+232.1%
- New buys
- 1
- Full exits
- 1